TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)
暂无分享,去创建一个
A. Sato | M. Suzuki | S. Koyama | H. Nishikawa | N. Yamamoto | K. Shitara | A. Kawazoe | H. Taniguchi | Y. Naito | Y. Kuboki | M. Wakabayashi | M. Suzuki | D. Kotani | K. Harano | M. Fukutani | Tsukiko Higuchi | K. Itahashi | T. Ikeno | Mitsuko Suzuki